Reappointment of Mr. Singarababu Indirakumar (DIN: 00892351) as a Whole-time Director for a period of five years
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech's board approved multiple items on 30 August 2025, including reappointment of Mr. Singarababu Indirakumar as Whole-time Director for five years. The board also approved disinvestment from material subsidiary Dindigul Farm Product Limited (DFPL), which contributed Rs. 6,282.81 lakhs (47.11%) to consolidated turnover and Rs. 3,521.13 lakhs (35.24%) to consolidated net worth as of 31 March 2025. Authorized share capital is being raised to Rs. 85 crore (8.5 crore equity shares of Rs. 10 each), and a new Independent Director, Dr. Bokara Nagarajan Padmaja Priyadarshini, was appointed for five years. Material related party transactions of up to Rs. 25 crore each were approved with five subsidiaries. The 33rd AGM is scheduled for 29 September 2025 via video conferencing.
The DFPL disinvestment is the most material item — DFPL contributed nearly half of consolidated revenue, so exiting this subsidiary could significantly reshape the company's revenue base and business mix. The share capital hike to Rs. 85 crore signals room for potential future fundraising or stock splits.